JP2001504446A5 - - Google Patents

Download PDF

Info

Publication number: JP2001504446A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

JP1998509527A

Other languages

English (en)

Other versions

JP2001504446A (ja

Filing date

1997-08-06

Publication date

2005-04-07

1996-08-09 Priority claimed from HU9602204A external-priority patent/HUP9602204D0/hu

1997-08-04 Priority claimed from HU9701349A external-priority patent/HUP9701349A1/hu

1997-08-06 Application filed filed Critical

1997-08-06 Priority claimed from PCT/HU1997/000044 external-priority patent/WO1998006400A2/en

2001-04-03 Publication of JP2001504446A publication Critical patent/JP2001504446A/ja

2005-04-07 Publication of JP2001504446A5 publication Critical patent/JP2001504446A5/ja

Status Ceased legal-status Critical Current

Description

JP50952798A 1996-08-09 1997-08-06 血管内皮細胞の損傷から生じる疾患を治療・予防するための医薬品 Ceased JP2001504446A (ja)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
HU9602204A HUP9602204D0 (en)	1996-08-09	1996-08-09	Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells
HU9701349		1997-08-04
HU9701349A HUP9701349A1 (hu)	1997-08-04	1997-08-04	Gyógyászati készítmények a vaszkuláris endoteliális sejtek rendellenes működésével összefüggő betegségek gyógyítására vagy megelőzésére
HU9602204		1997-08-04
PCT/HU1997/000044 WO1998006400A2 (en)	1996-08-09	1997-08-06	Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells

Publications (2)

Publication Number	Publication Date
JP2001504446A JP2001504446A (ja)	2001-04-03
JP2001504446A5 true JP2001504446A5 (ja)	2005-04-07

Family

ID=90014231

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP50952798A Ceased JP2001504446A (ja)	1996-08-09	1997-08-06	血管内皮細胞の損傷から生じる疾患を治療・予防するための医薬品

Country Status (20)

Country	Link
US (1)	US6143741A (ja)
EP (1)	EP0966283B1 (ja)
JP (1)	JP2001504446A (ja)
AT (1)	ATE329592T1 (ja)
AU (1)	AU739614B2 (ja)
BG (1)	BG64456B1 (ja)
CA (1)	CA2262997C (ja)
CZ (1)	CZ298542B6 (ja)
DE (1)	DE69736130T2 (ja)
DK (1)	DK0966283T3 (ja)
EE (1)	EE04044B1 (ja)
ES (1)	ES2267148T3 (ja)
HK (1)	HK1025506A1 (ja)
IL (1)	IL128256A (ja)
NO (1)	NO325109B1 (ja)
PT (1)	PT966283E (ja)
RS (1)	RS49719B (ja)
SK (1)	SK284301B6 (ja)
UA (1)	UA64716C2 (ja)
WO (1)	WO1998006400A2 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU9701081D0 (en)	1997-06-23	1997-08-28	Gene Research Lab Inc N	Pharmaceutical composition of antitumoral activity
HU226617B1 (en) *	1998-12-14	2009-04-28	Cytrx Corp	Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
HUP9900475D0 (en) *	1999-02-26	1999-04-28	Biorex Kutato Fejlesztoe Kft	O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
RU2320330C2 (ru)	2002-01-11	2008-03-27	СиУайТиАрЭкс КОРПОРЕЙШН	Производные карбоксамидина и их использование при лечении заболеваний сосудов
HUP0303584A3 (en)	2003-10-30	2009-12-28	Cytrx Corp	Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
US20080227813A1 (en) *	2006-09-26	2008-09-18	Jack Raymond Barber	Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
WO2008070010A2 (en) *	2006-12-01	2008-06-12	Cytrx Corporation	Hydroxylamine derivatives for the treatment of stroke
TW200901958A (en) *	2007-05-04	2009-01-16	Cytrx Corp	Diabetic wound healing
JP5429865B2 (ja) *	2009-09-15	2014-02-26	学校法人日本大学	生体外創傷治癒試験用用具または創傷作製方法
HUP1100535A2 (en) *	2011-09-26	2013-04-29	Bracelia Invest Ltd	Pharmaceutical composition for enhancement of stem cell treatment
US9802927B2 (en)	2015-06-10	2017-10-31	Denali Therapeutics, Inc.	Oxadiazine compounds and methods of use thereof
MX2023005954A (es)	2020-11-19	2023-09-04	Zevra Denmark As	Procesos para preparar citrato de arimoclomol e intermediarios del mismo.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4187220A (en) *	1977-08-30	1980-02-05	Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T.	New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU207988B (en) *	1988-10-20	1993-07-28	Biorex Kutato Fejlesztoe Kft	Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
GB9017351D0 (en) *	1990-08-08	1990-09-19	Wellcome Found	Medicaments for treatment of atherosclerosis
MX9605376A (es) *	1994-05-06	1998-05-31	Biorex Kutato Fejlesztoe Kft	Derivados novedosos de acido hidroximico, composiciones farmaceuticas que los contienen y procesos para preparar los mismos.
HU218480B (hu) *	1995-06-15	2000-09-28	BIOREX Kutató és Fejlesztő Rt.	Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HU222994B1 (hu) *	1995-11-02	2004-01-28	BIOREX Kutató és Fejlesztő Rt.	Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására

1997
- 1997-06-08 UA UA99020697A patent/UA64716C2/uk unknown
- 1997-08-06 EP EP97933813A patent/EP0966283B1/en not_active Expired - Lifetime
- 1997-08-06 EE EEP199900044A patent/EE04044B1/xx not_active IP Right Cessation
- 1997-08-06 WO PCT/HU1997/000044 patent/WO1998006400A2/en active IP Right Grant
- 1997-08-06 ES ES97933813T patent/ES2267148T3/es not_active Expired - Lifetime
- 1997-08-06 RS YUP-51/99A patent/RS49719B/sr unknown
- 1997-08-06 IL IL12825697A patent/IL128256A/en not_active IP Right Cessation
- 1997-08-06 JP JP50952798A patent/JP2001504446A/ja not_active Ceased
- 1997-08-06 AT AT97933813T patent/ATE329592T1/de active
- 1997-08-06 DK DK97933813T patent/DK0966283T3/da active
- 1997-08-06 CA CA002262997A patent/CA2262997C/en not_active Expired - Fee Related
- 1997-08-06 SK SK154-99A patent/SK284301B6/sk not_active IP Right Cessation
- 1997-08-06 PT PT97933813T patent/PT966283E/pt unknown
- 1997-08-06 CZ CZ0043599A patent/CZ298542B6/cs not_active IP Right Cessation
- 1997-08-06 DE DE69736130T patent/DE69736130T2/de not_active Expired - Lifetime
- 1997-08-06 US US09/230,941 patent/US6143741A/en not_active Expired - Fee Related
- 1997-08-06 AU AU37049/97A patent/AU739614B2/en not_active Ceased
1999
- 1999-02-05 NO NO19990547A patent/NO325109B1/no not_active IP Right Cessation
- 1999-02-22 BG BG103194A patent/BG64456B1/bg unknown
2000
- 2000-06-28 HK HK00103903A patent/HK1025506A1/xx not_active IP Right Cessation

Publication	Publication Date	Title
JP2000502280A5 (ja)	2005-06-16
JP2000506165A5 (ja)	2005-02-10
JP2000501771A5 (ja)	2004-08-19
JP2000512172A5 (ja)	2004-11-04
JP2000501018A5 (ja)	2005-05-12
JP2000500076A5 (ja)	2005-07-14
JP2000501324A5 (ja)	2005-05-12
JP2000500055A5 (ja)	2005-04-07
JP2000500026A5 (ja)	2004-10-21
JP2000504992A5 (ja)	2004-11-25
JP2000501338A5 (ja)	2005-05-12
JP2000501825A5 (ja)	2005-04-07
JP2000500874A5 (ja)	2005-04-07
JP2000501774A5 (ja)	2005-04-07
JP2000502570A5 (ja)	2004-11-18
JP2000507952A5 (ja)	2004-12-02
JP2000502568A5 (ja)	2004-11-11
JP2000500912A5 (ja)	2005-02-10
JP2000517129A5 (ja)	2005-04-07
JP2000501876A5 (ja)	2005-04-07
JP2000500857A5 (ja)	2005-03-10
JP2000501229A5 (ja)	2005-04-07
JP2000502714A5 (ja)	2004-11-11
JP2000500318A5 (ja)	2005-04-07
JP2000501569A5 (ja)	2005-05-12